Abstract:Objective:To investigate the effect of SH3BP4 on the migration and proliferation of hepatocarcinoma cells by the construction of SH3BP4 recombinant adenovirus vector and lentiviral vector. Methods :The SH3BP4 cDNA sequence was amplified and then the recombinant Adplasmid pAdTrack-SH3BP4 was constructed. The recombinant adenovirus Ad-SH3BP4 was packaged and amplified by using HEK293 cells. The short hairpin RNA recombinant lentiviral vector of SH3BP4 was constructed and transfected into HEK293 T cells, then the recombinant lentivi-ruses shSH3BP4 was packaged and amplified. The endogenous expression of SH3BP4 in normal human hepatocytes and hepatocarcinoma cells was examined by the Western blot. The SH3BP4 overexpression experiment was divided into three groups:mock group (the blank control group) , AdGFP group (the control group of those were infected with adenovirus AdGFP) and AdSH3BP4 group (the experimental group of those were infected with adenovirus AdSH3BP4) ;the SH3BP4 knockdown experiment was divided into two groups, sh Control group, the control group of those were infected with lentiviruses PLL3.7 vector, and shSH3BP4 group, the experimental group of those were infected with lentiviruses shSH3BP4.The effect on the migration of hepatocarcinoma cells was observed by the Transwell and wound healing assay, and the effect on the proliferation was observed by the MTS and colony formation assay. Results:A recombinant adenovirus AdSH3BP4 and a recombinant lentiviral shSH3BP4 were successfully constructed, verified by the restriction endonuclease and DNA sequencing. The Transwell assay showed that the number of cell migration in AdSH3BP4 group (74.800±0.544) significantly decreased compared with that in mock group (219.467±2.640) and AdGFP group (210.533±8.498) (P=0.000) . In contrast, the number of cell migration in shSH3BP4 group (191.467±3.906) increased significantly compared with that in sh Control group (91.733±2.763) (P=0.000) . The wound healing assay showed that the cell repair rate in AdSH3BP4 group[ (10.400±0.036) ％] was lower than that in mock group[ (37.500±0.063) ％] and AdGFP group[ (50.000±0.063) ％] (P＜0.000) , but it was significantly higher in shSH3BP4 group[ (55.00±0.05) ％] compared with that in sh Control group[ (23.300±0.029) ％] (P=0.000) . The MTS assay showed that the absorbance value at 96 h in AdSH3BP4 group (0.921±0.053) decreased significantly compared with that in black control group (1.091±0.043) and AdGFP group (1.062±0.024) , while it was significantly higher in shSH3BP4 group (1.497±0.020) compared with that in sh Control group (1.142±0.103) (P=0.004) .The colony formation assay showed that the number of clone forming cells in AdSH3BP4 group (34.333±2.082) significantly decreased compared with that in mock group (86.333±4.726) and AdGFP control group (87.333±1.528) (P=0.000) , but it was significantly higher in shSH3BP4 group (65.000±6.557) compared with that in sh Control (31.000±2.000) (P=0.001) . Conclusion:SH3BP4 can inhibit the migration, invasion and proliferation of hepatocarcinoma cells, and it may provide a new target for the diagnosis and treatment of liver cancers.

Role of GSK-3β in Hepatocellular Carcinoma Cell Migration

In-vitro Study of Glycogen Synthase Kinase-3Β on Regulation of Migration, Invasion and Epithelial-Mesenchymal Transition in Pancreatic Cancer Cells

Effect of GSK-3β on Proliferation and Invasion of Endometrioid Adenocarcinoma

GSK3B inhibition reduced cervical cancer cell proliferation and migration by modulating the PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition

β-Sitosterol alleviates the malignant phenotype of hepatocellular carcinoma cells via inhibiting GSK3B expression

Stat3 and Beta-Catenin Signaling Pathway May Affect Gsk-3 Beta Expression in Hepatocellular Carcinoma

Knockdown of Golgi Phosphoprotein 2 Inhibits Hepatocellular Carcinoma Cell Proliferation and Motility

Inhibition of GSK-3β Activity Suppresses HCC Malignant Phenotype by Inhibiting Glycolysis Via Activating AMPK/mTOR Signaling.

Effects of SH3BP4 gene on the migration and proliferation of hepatocarcinoma cells

Effect of inhibition of Hedgehog signaling pathway on the growth and migration of hepatocellular carcinoma cells

Evaluation of the effect of GSK-3β on liver cancer based on the PI3K/AKT pathway

GSK3β Overexpression Indicates Poor Prognosis and Its Inhibition Reduces Cell Proliferation and Survival of Non-Small Cell Lung Cancer Cells

The effect of Phosphoinositide-3-kinase, regulatory subunit 3 in epithelial-mesenchymal transition and migration of non-small cell lung cancer

Effects of Glycogen Synthase Kinase3β Silencing on Cell Growth and Epithelial-Mesenchymal Transition in Pancreatic Cancer PANC1 Cells

The Role of Glycogen Synthase Kinase 3β in the Transformation of Epidermal Cells

The Role Of Glycogen Synthase Kinase 3 Beta In The Transformation Of Epidermal Cells

Role of GSK-3β Activation in Responses of Colorectal Cancer Cells to EGFR and IGFR-1 Inhibitor

GSK3β-Ikaros-ANXA4 signaling inhibits high-glucose-induced fibroblast migration

Glypican-3 Promotes Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells Through Erk Signaling Pathway

Glycogen Synthase Kinase-3Β Regulates Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (Trail)-Induced Apoptosis Via the NF-κB Pathway in Hepatocellular Carcinoma.

Role of PKCβ in Hepatocellular Carcinoma Cells Migration and Invasion in Vitro: a Potential Therapeutic Target